Moderna, Inc. (ETR:0QF)
22.77
-1.28 (-5.30%)
At close: Oct 10, 2025
Moderna Revenue
Moderna had revenue of $142.00M USD in the quarter ending June 30, 2025, a decrease of -41.08%. This brings the company's revenue in the last twelve months to $3.08B, down -39.05% year-over-year. In the year 2024, Moderna had annual revenue of $3.24B, down -52.75%.
Revenue (ttm)
$3.08B
Revenue Growth
-39.05%
P/S Ratio
3.44
Revenue / Employee
$530.69K
Employees
5,800
Market Cap
9.02B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.24B | -3.61B | -52.75% |
Dec 31, 2023 | 6.85B | -12.42B | -64.45% |
Dec 31, 2022 | 19.26B | 792.00M | 4.29% |
Dec 31, 2021 | 18.47B | 17.67B | 2,200.25% |
Dec 31, 2020 | 803.00M | 743.00M | 1,238.33% |
Dec 31, 2019 | 60.00M | -75.07M | -55.58% |
Dec 31, 2018 | 135.07M | -70.76M | -34.38% |
Dec 31, 2017 | 205.83M | 97.43M | 89.88% |
Dec 31, 2016 | 108.40M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Moderna News
- 1 day ago - MRNA: Morgan Stanley Raises Price Target for Moderna | MRNA Stock News - GuruFocus
- 3 days ago - Updated COVID shot led to less severe illness, fewer hospitalizations last year, US study finds - Yahoo
- 3 days ago - Noteworthy Wednesday Option Activity: MRNA, APGE, EU - Nasdaq
- 5 days ago - Moderna (MRNA) COVID-19 Booster Recommendations Updated by CDC - GuruFocus
- 9 days ago - November 14th Options Now Available For Moderna (MRNA) - Nasdaq
- 9 days ago - Could MRNA's Upcoming Product Launches Reduce COVID Sales Dependency? - Nasdaq
- 10 days ago - Noteworthy Wednesday Option Activity: TMO, MRNA, AES - Nasdaq
- 10 days ago - Moderna Stock Is Rallying Wednesday: What's Driving The Action? - Benzinga